Company intelligence / Profile preview

Highbridge Capital Management

New York, NY, USA

Ownership: Private
Employees: ~465
Development stage: Other

Overview

Highbridge Capital Management is an alternative investment fund manager focused on credit and volatility strategies, sometimes investing in healthcare and biotech companies as part of its diversified portfolio. It was acquired by J.P. Morgan Asset Management in 2009 and is currently operated as its subsidiary, managing institutional, endowment, and high net-worth capital across global markets[1][3][5][7].

Industry: Investors

Partnerships

Gávea Investimentos

Beyond the preview

Go deeper on Highbridge Capital Management.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Highbridge Capital Management.

Explore the full profile